Ledger.Open graph →
SEC Form D · Amendment · filed March 25, 2025

Paragon Biosciences Emalex Capital, Inc

Offering
$242.0M
Sold
$217.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CHICACO, IL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Eric J. Messner · Chicago, ILExec · DirectorDavid Tingley · Naples, FLDirectorRicky J. Sun · Chicago, ILDirectorKevin Chavers · New York, NYDirectorJeffrey J. Dayno · Chicago, ILDirectorJeffrey J. Dayno · Chicago, ILDirectorAl C. Laskaj · NEW YORK, NYDirectorJames L. Alt · New York, NYExec · DirectorMichael L. Appel · New York, NYDirectorAmit Assaraf · New York, NYExecWilliam D. Rahm · New York, NYExecEric J. Messner · Chicago, ILExec · DirectorJeffrey J. Aronin · Chicago, ILDirectorRicardo Lombardi · New York, NYDirectorDarien J. Parhad · Chicago, ILExecRicky J. Sun · Chicago, ILDirectorDana C. Devivo · NEW YORK, NYExecAntonio J. Gracias · Chicago, ILDirectorPatrick J. Morris · Chicago, ILExecFrancis C. Poli · NEW YORK, NYExecPatrick N. Nolan · Atlanta, GADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗